These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch. Takai S; Shiota N; Yamamoto D; Okunishi H; Miyazaki M Life Sci; 1996; 58(7):591-7. PubMed ID: 8632712 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin II generation by mast cell alpha- and beta-chymases. Caughey GH; Raymond WW; Wolters PJ Biochim Biophys Acta; 2000 Jul; 1480(1-2):245-57. PubMed ID: 10899625 [TBL] [Abstract][Full Text] [Related]
4. The conversion of recombinant human mast cell prochymase to enzymatically active chymase by dipeptidyl peptidase I is inhibited by heparin and histamine. McEuen AR; Ashworth DM; Walls AF Eur J Biochem; 1998 Apr; 253(1):300-8. PubMed ID: 9578489 [TBL] [Abstract][Full Text] [Related]
5. Secretory production of recombinant human chymase as an active form in Pichia pastoris. Nakakubo H; Fukuyama H; Nakajima M; Imada T; Uno S; Shiota N; Takai S; Miyazaki M; Nakamura N Yeast; 2000 Mar; 16(4):315-23. PubMed ID: 10669869 [TBL] [Abstract][Full Text] [Related]
6. Recombinant human chymase produced by silkworm-baculovirus expression system: its application for a chymase detection kit. Suzuki T; Kaki H; Naya S; Murayama S; Tatsui A; Nagai A; Takai S; Miyazaki M Jpn J Pharmacol; 2002 Nov; 90(3):210-3. PubMed ID: 12499573 [TBL] [Abstract][Full Text] [Related]
7. Dipeptide processing activates recombinant human prochymase. Urata H; Karnik SS; Graham RM; Husain A J Biol Chem; 1993 Nov; 268(32):24318-22. PubMed ID: 8226981 [TBL] [Abstract][Full Text] [Related]
8. Functional reconstitution of an active recombinant human chymase from Pichia pastoris cell lysate. Nakakubo H; Morita M; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N Yeast; 2000 Nov; 16(15):1387-96. PubMed ID: 11054819 [TBL] [Abstract][Full Text] [Related]
9. Characterization of recombinant human chymase expressed in Escherichia coli. Takai S; Sumi S; Aoike M; Sakaguchi M; Itoh Y; Jin D; Matsumura E; Miyazaki M Jpn J Pharmacol; 2000 Feb; 82(2):144-9. PubMed ID: 10877533 [TBL] [Abstract][Full Text] [Related]
10. Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis. Arakawa K; Urata H Hypertension; 2000 Oct; 36(4):638-41. PubMed ID: 11040250 [TBL] [Abstract][Full Text] [Related]
11. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases. Liao Y; Husain A Can J Cardiol; 1995 Aug; 11 Suppl F():13F-19F. PubMed ID: 7664213 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human mast-cell chymase: an improved procedure for expression in Pichia pastoris and purification of the highly active enzyme. Lockhart BE; Vencill JR; Felix CM; Johnson DA Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):89-95. PubMed ID: 15163313 [TBL] [Abstract][Full Text] [Related]
13. Characterization of chymase from human vascular tissues. Takai S; Shiota N; Sakaguchi M; Muraguchi H; Matsumura E; Miyazaki M Clin Chim Acta; 1997 Sep; 265(1):13-20. PubMed ID: 9352125 [TBL] [Abstract][Full Text] [Related]
14. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity. Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257 [TBL] [Abstract][Full Text] [Related]
15. Alpha 2-macroglobulin capture allows detection of mast cell chymase in serum and creates a reservoir of angiotensin II-generating activity. Raymond WW; Su S; Makarova A; Wilson TM; Carter MC; Metcalfe DD; Caughey GH J Immunol; 2009 May; 182(9):5770-7. PubMed ID: 19380825 [TBL] [Abstract][Full Text] [Related]
16. Suppression of basic fibroblast growth factor-induced angiogenesis by a specific chymase inhibitor, BCEAB, through the chymase-angiotensin-dependent pathway in hamster sponge granulomas. Muramatsu M; Yamada M; Takai S; Miyazaki M Br J Pharmacol; 2002 Oct; 137(4):554-60. PubMed ID: 12359638 [TBL] [Abstract][Full Text] [Related]
17. Chymase-dependent angiotensin II formation in the saphenous vein versus the internal thoracic artery. Nishimoto M; Takai S; Sawada Y; Yuda A; Kondo K; Yamada M; Jin D; Sakaguchi M; Asada K; Sasaki S; Miyazaki M J Thorac Cardiovasc Surg; 2001 Apr; 121(4):729-34. PubMed ID: 11279415 [TBL] [Abstract][Full Text] [Related]
18. Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease. McPherson EA; Luo Z; Brown RA; LeBard LS; Corless CC; Speth RC; Bagby SP J Am Soc Nephrol; 2004 Feb; 15(2):493-500. PubMed ID: 14747398 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension. Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764 [TBL] [Abstract][Full Text] [Related]
20. Effect of Angiotensin II Type 1 receptor blocker on cardiac angiotensin-converting enzyme and chymase-like activities, and cardiac fibrosis in cardiomyopathic hamsters. Shimizu M; Tanaka R; Uchida M; Orito K; Shimamura S; Yamane Y J Vet Med Sci; 2006 Mar; 68(3):227-33. PubMed ID: 16598165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]